Market Cap 509.06M
Revenue (ttm) 41.24M
Net Income (ttm) -400.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -971.56%
Debt to Equity Ratio 0.00
Volume 1,598,300
Avg Vol 1,658,554
Day's Range N/A - N/A
Shares Out 61.48M
Stochastic %K 47%
Beta 0.82
Analysts Sell
Price Target $8.35

Latest News on SAGE

Sage Therapeutics Announces R&D Leadership Transition

Mar 4, 2025, 4:15 PM EST - 27 days ago

Sage Therapeutics Announces R&D Leadership Transition


Sage Therapeutics, Inc. (SAGE) Q4 2024 Earnings Call Transcript

Feb 11, 2025, 9:29 PM EST - 6 weeks ago

Sage Therapeutics, Inc. (SAGE) Q4 2024 Earnings Call Transcript


Sage Therapeutics, Inc. (SAGE) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 9:35 PM EDT - 5 months ago

Sage Therapeutics, Inc. (SAGE) Q3 2024 Earnings Call Transcript